Aclarion Financials

ACON Stock  USD 0.18  0.01  5.88%   
Based on the analysis of Aclarion's profitability, liquidity, and operating efficiency, Aclarion may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Aclarion's Total Liabilities is very stable compared to the past year. As of the 23rd of November 2024, Net Invested Capital is likely to grow to about 417.6 K, while Total Assets are likely to drop about 2.3 M. Key indicators impacting Aclarion's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio0.320.4045
Significantly Down
Slightly volatile
Investors should never underestimate Aclarion's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aclarion's cash flow, debt, and profitability to make informed and accurate decisions about investing in Aclarion.

Net Income

(5.16 Million)

  
Understanding current and past Aclarion Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aclarion's financial statements are interrelated, with each one affecting the others. For example, an increase in Aclarion's assets may result in an increase in income on the income statement.

Aclarion Stock Summary

Aclarion competes with EUDA Health, FOXO Technologies, Healthcare Triangle, Mangoceuticals, Common, and HealthStream. Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS6551871022
CUSIP655187102 655187201
LocationCalifornia; U.S.A
Business Address8181 Arista Place,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.aclarion.com
Phone833 275 2266
CurrencyUSD - US Dollar

Aclarion Key Financial Ratios

Aclarion Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aclarion's current stock value. Our valuation model uses many indicators to compare Aclarion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aclarion competition to find correlations between indicators driving Aclarion's intrinsic value. More Info.
Aclarion is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Aclarion's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aclarion's earnings, one of the primary drivers of an investment's value.

Aclarion Systematic Risk

Aclarion's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aclarion volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Aclarion correlated with the market. If Beta is less than 0 Aclarion generally moves in the opposite direction as compared to the market. If Aclarion Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aclarion is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aclarion is generally in the same direction as the market. If Beta > 1 Aclarion moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Aclarion Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aclarion's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aclarion growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.00604

At this time, Aclarion's Price Earnings To Growth Ratio is very stable compared to the past year.

Aclarion November 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Aclarion help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aclarion. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aclarion based on widely used predictive technical indicators. In general, we focus on analyzing Aclarion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aclarion's daily price indicators and compare them against related drivers.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclarion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.40)
Revenue Per Share
0.015
Quarterly Revenue Growth
(0.36)
Return On Assets
(1.15)
Return On Equity
(7.14)
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.